Mechanism of Action
The pharmacodynamics of lamotrigine is based on interaction with nerve cell ion channels. The drug blocks voltage-gated $Na^+$ channels located on neuronal membranes, acting predominantly at the presynaptic terminals.
The direct consequence of this blockade is an alteration in synaptic transmission. Inhibiting the inward sodium current significantly decreases the release of glutamate from presynaptic terminals. Because glutamate is the primary excitatory neurotransmitter in the central nervous system, reducing its concentration in the synaptic cleft prevents excessive neuronal firing and epileptic discharges.
Clinical Application in Epilepsy
The drug features an exceptionally broad spectrum of activity, allowing it to be prescribed for almost all known forms of epilepsy. This makes it a versatile tool in the neurologist's armamentarium.
Types of seizures controlled:
- Partial (focal) seizures;
- Major convulsive seizures (generalized tonic-clonic);
- Minor seizures, also known as absence seizures.
Place in therapeutic regimens: Lamotrigine is particularly valuable in complex clinical cases. It is actively used to treat epilepsy that is resistant to other anticonvulsant drugs. Additionally, it is frequently used as adjunctive therapy (as an adjuvant) to enhance the effect of the primary treatment regimen.
Adverse Effects
Despite its high efficacy, therapy carries the risk of several adverse effects affecting various body systems.
- Central nervous system (CNS): Patients may report drowsiness, headache, and dizziness. Coordination disorders (ataxia), tremors, and double vision (diplopia) may also occur.
- Gastrointestinal tract (GI): Nausea is the most common gastrointestinal complaint.
- Dermatological reactions: A specific and critical adverse effect is skin rash, which can develop during treatment.